Search

Search Results
Results 491 - 500 of 805 for Male breast cancer
  • News - 2 Nov 2004
    Deaths from cardiac valve diseases appear to run in families, suggesting a significant genetic component, according to a study published in Circulation: Journal of the American Heart Association.
  • News - 10 Jun 2004
    Early results from a University of North Carolina at Chapel Hill School of Medicine study may determine if drugs called Cox-2 inhibitors, a newer type of non-aspirin pain medicine now widely...
  • Drug - 26 May 2026
    Consumer Medicine Information (CMI) about Duodart intended for persons living in Australia.
  • Drug - 26 May 2026
    Consumer Medicine Information (CMI) about Doubluts intended for persons living in Australia.
  • Drug - 24 Apr 2026
    Consumer Medicine Information (CMI) about Testavan intended for persons living in Australia.
  • Drug - 24 Apr 2026
    Consumer Medicine Information (CMI) about Tagrisso intended for persons living in Australia.
  • Drug - 22 Apr 2026
    Consumer Medicine Information (CMI) about Diphereline intended for persons living in Australia.
  • News - 23 Feb 2026
    After a grueling year of chemotherapy, surgery, and radiation to treat breast cancer, Sadia Zapp was anxious — not the manageable hum that had long been part of her life, but something deeper, more...
  • Drug - 23 Jan 2026
    Consumer Medicine Information (CMI) about Dutasteride/tamsulosin Viatris 500/400 intended for persons living in Australia.
  • News - 19 Jan 2026
    A nationwide Australian pilot screened more than 10,000 adults aged 18–40 years for high-risk genetic variants linked to hereditary cancer and familial hypercholesterolaemia, identifying clinically...

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.